Below are the most recent publications written about "Indoles" by people in Profiles.
-
Adeyinka OS, Metibemu DS, Hampton T, Ojobor JC, Crown O, Falode J, Barrera MD, Alem F, Narayanan A, Ogungbe IV. Broad-spectrum inhibitor of non-structural protein 2 protease shows therapeutic efficacy against Venezuelan equine encephalitis viral infection. Eur J Med Chem. 2026 Apr 15; 308:118696.
-
Sarkar M, Du T, Chen Y, Lawrence YVM, Ma J, Khan SA, Oyelere AK, Liang D, Gao S, Xie H. Preclinical Development of GT-14, a Novel Inhibitor of Gai2 Protein: Comprehensive Evaluation of Physicochemical, Metabolic Characteristics and Tissue Distribution. AAPS J. 2025 12 01; 28(1):23.
-
Mondal T, Sahoo P, Nandi SK, Kundu S, Li M, Haldar N, Kabir R, Mitra K, Roy S, Das M, Ghosh CK. Opto-magnetic optimization enhances the multimodal therapeutic and diagnostic (UCL/T1-T2W MRI) potential of GdOF against MDA-MB-231. J Mater Chem B. 2025 Aug 13; 13(32):9993-10008.
-
Kim J, Lim JW, Kim HO, Park J, Jeong E, Park C, Park G, Yeom M, Song D, Lim EK, Haam S. Hemagglutinin docking analysis-based visual detection of antiviral therapeutic efficacy of umifenovir against influenza virus. Biosens Bioelectron. 2025 Nov 01; 287:117762.
-
Dela Cruz MC, Yao X, Roberts N, Iheukwumere P, Carmouche A, Medina PM, Biliran H. TLE1 drives EGFR-TKI resistance in EGFR-mutant lung adenocarcinoma through epithelial to mesenchymal transition. Biochem Biophys Res Commun. 2025 08 15; 775:152146.
-
Lee HJ, Lee NK, Kim J, Kim J, Seo D, Shin HE, Kim J, Ahn JH, Kim SN, Kim HS, Park J, Park W, Hong KS, Park CG, Lee W. Sequential nanoparticle therapy targeting neutrophil hyperactivation to prevent neutrophil-induced pulmonary fibrosis. J Nanobiotechnology. 2025 May 26; 23(1):381.
-
Nathani A, Sun L, Li Y, Lazarte J, Aare M, Singh M. Targeting EGFR-TKI resistance in lung cancer: Role of miR-5193/miR-149-5p loaded NK-EVs and Carboplatin combination. Int J Pharm. 2025 Apr 30; 675:125573.
-
Bornes KE, Moody MA, Huckaba TM, Benz MC, McConnell EC, Foroozesh M, Barnes VH, Collins-Burow BM, Burow ME, Watt TJ, Toro TB. Lysine deacetylase inhibitors have low selectivity in cells and exhibit predominantly off-target effects. FEBS Open Bio. 2025 Jan; 15(1):94-107.
-
Nathani A, Khan I, Tanimoto MH, Mej?a JAA, DE Miranda AM, Rishi A, Dev S, Bastos JK, Singh M. Antitumor Potential of Guttiferone E Combined With Carboplatin Against Osimertinib-resistant H1975 Lung Cancer Through Apoptosis. Anticancer Res. 2024 Oct; 44(10):4175-4188.
-
Shi Y, Lai Y, Guo Y, Cai Z, Mao C, Lu M, Ren C, Ong JL, Chen W. Aspirin/amoxicillin loaded chitosan microparticles and polydopamine modified titanium implants to combat infections and promote osteogenesis. Sci Rep. 2024 04 01; 14(1):7624.